Becky Davis of Charles River Associates predicts that an influx of new and oral GLP-1 drugs, along with pricing pressures ...

Eli Lilly's (LLY) stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound. CVS Health said the drugs Wegovy and Saxenda from rival drugmaker ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type ... both inflammation and scarring was more modest in comparison to what was seen with Wegovy, according to ...

Eli Lilly, the drugmaker behind the blockbuster weight loss drug ... coverage for the drug and couldn't afford Zepbound sticker price of more than $1,086.37 a month. For comparison, compounded ...

It found participants lost 7.9lbs (3.6kg) on average in just under three months, with some losing up to 10 per cent of their body weight. By comparison ... taking weight-loss drugs Oxford ...

This once-daily pill offers a convenient, alternative to blockbuster drugs like ... even more weight. By comparison, Lilly’s injectable Zepbound achieved 15.3% to 36.2% weight loss in a 72 ...